Vertebral compression fractures (VCF) arise due to various aetiologies including osteoporosis, osteolytic metastasis and multiple myeloma. These VCFs may be treated with infiltration of cancellous bone with polymethyl methacrylate (PMMA) bone cement to stabilise the fracture site and provide pain relief. The first generation of percutaneous vertebroplasty (PVP) was developed in 1987 [1], with the injection of bone cement into the vertebral body via a percutaneously inserted cannula under pressure. The pressure on the bone cement would cause interdigitation of porous channels between the cancellous trabeculae to provide pain relief and prevent further collapse. Limitations inherent to PVP are cement leaks caused by cement pressurisation [2, 3] and the presence of large open vascular channels [4]. PVP is also unable to actively reduce vertebral body kyphosis, leading to an increased risk of adjacent segment fractures due to altered spinal biomechanics and alignment [5].
Balloon kyphoplasty (BKP) introduced 1998, addressed the deficiencies of PVP. This utilised a percutaneously placed inflatable balloon to both reduce the fracture site, restore spinal alignment, and create a low pressure void to allow for a more viscous bone cement mixture to flow under much lower pressure [6]. This succeeded in improving spinal alignment and reducing bone cement leakage [7].
Vertebral Body Stenting (Synthes, Oberdorf, Switzerland) (VBS), introduced in 2010 [8] refined BKP by adding a metallic stent to be expanded and deployed by an inflatable balloon within the fractured vertebral body. After the balloon was deflated and retrieved, the stent would effectively maintain fracture reduction and reduce the loss of vertebral body height after the momentary absence of support prior to cementation [9] (Fig. 1).
The evolution of vertebral body cementing techniques from PVP to VBS Stentoplasty is of improved fracture reduction, maintenance of vertebral height and reduced cement leakage rates at the tradeoff of requiring increased hardware being introduced to the fracture site. As a highly minimally invasive procedure with small incisions, PVP wounds can be closed with Skin Adhesive Tapes (SATs) alone. Compared to PVP cannulas, the VBS access kit requires a working sleeve of 4.7mm in diameter as opposed to 2.59mm. This 330% increase in surface area is necessary to accommodate both the metallic stent and inflatable balloon for deployment. In addition, the implantation of metal stents demands precise placement of the access kit compared to the larger and more forgiving target area for cement portal placement in PVP. VBS stentoplasty thus requires larger skin incisions, causes greater soft tissue trauma and generates a bigger pedicle bore tract with exposed cancellous bone. These factors increase the risk of bleeding and wound complications.
SATs are a common modality of wound closure, having the capacity to provide mechanical and strangulation-free support for wounds. It opposes the superficial wound edges with minimal tension, providing similar tensile strength as skin sutures while maintaining epidermal integrity [10]. They are typically used in conjunction with subdermal or subcuticular sutures in larger wounds but have shown reasonable reliability when used in isolation on lacerations or smaller surgical incisions. Compared to conventional suture closure, SATs have been found to deliver comparable [11] or better cosmetic results, and require less time for closure [12]. Complications associated with SATs are rare but include contact dermatitis, tension blisters, tape dislodgement, wound dehiscence and wound infection [13]. This study aims to evaluate the effectiveness, safety and cosmesis of skin adhesive tapes in the closure of VBS Stentoplasty wounds.